Yuehong Kong - The Second Affiliated Hospital, Soochow University

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluation of the Efficacy and Safety of a Precise Thymalfasin-Regulated PRaG Regimen for Advanced Refractory Solid Tumours: Protocol for the Open-Label, Prospective, Multicentre Study (prag5.0 Study)

Yuehong Kong,Rongzheng Chen,Meiling Xu,Junjun Zhang,Guangqiang Chen,Zhihui Hong, Hong Zhang,Xiaoxiao Dai,Yifu Ma,Xiangrong Zhao, Yong Peng, Chenyang Zhang,Pengfei Xing,Liyuan Zhang

BMJ OPENno. 3 (2024)

引用0浏览0WOS引用

A Precise Thymalfasin-Regulated PRaG Regimen for Advanced Refractory Solid Tumors: an Open-Label, Prospective, Multicenter Clinical Study (prag 5.0 Study)

Yuehong Kong,Meiling Xu, Shicheng Li,Rongzheng Chen,Xiangrong Zhao,Junjun Zhang,Pengfei Xing,Liyuan Zhang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

The Relationship Between Splenic Dose and Radiation-Induced Lymphopenia

Yifu Ma,Yuehong Kong,Shuying Zhang, Yong Peng,Meiling Xu,Junjun Zhang,Hong Xu,Zhihui Hong,Pengfei Xing,Jianjun Qian,Liyuan Zhang

JOURNAL OF RADIATION RESEARCHno. 3 (2024): 337-349

引用0浏览0WOS引用

PRaG 3.0 Therapy for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Pancreatic Ductal Adenocarcinoma: A Case Report

Yue-Hong Kong, Mei-Ling Xu,Jun-Jun Zhang,Guang-Qiang Chen,Zhi-Hui Hong, Hong Zhang,Xiao-Xiao Dai,Yi-Fu Ma, Xiang-Rong Zhao, Chen-Yang Zhang,Rong-Zheng Chen,Peng-Fei Xing,Li-Yuan Zhang

WORLD JOURNAL OF GASTROENTEROLOGYno. 9 (2024)

引用0浏览0WOS引用

Phase I/II Clinical Study of PRaG Regimen Combined with Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors with Cancerous Ascites (prag4.0p Study)

Yingying Xu,Yuehong Kong,Yifu Ma,Meiling Xu,Jiabao Yang,Junjun Zhang,Rongzheng Chen,Guangqiang Chen,Zhihui Hong,Xiangrong Zhao, Chenyang Zhang,Pengfei Xing,Liyuan Zhang,Peifeng Zhao

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2024)

引用0浏览0WOS引用

Safety and Efficacy of Loading-Dose Thymosin Α1 in Patients with Advanced and Refractory Solid Tumors with Lower Absolute T Lymphocyte

Meiling Xu,Xiangrong Zhao,Yuehong Kong,Pengfei Xing,Junjun Zhang,Liyuan Zhang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

“布拉格治疗”PD-1及PD-L1抑制剂耐药的晚期难治性非小细胞肺癌1例

徐美玲, 张辰阳,邢鹏飞,孔月虹,赵向荣, 张军军, 张力元

National Medical Journal of Chinano. 44 (2023)

引用0浏览0引用

PD-1 Inhibitor Combined with Radiotherapy and GM-CSF in MSS/pMMR Metastatic Colon Cancer: a Case Report

Jiabao Yang,Pengfei Xing,Yuehong Kong,Meiling Xu,Liyuan Zhang

Frontiers in oncology (2023)

引用0浏览0WOS引用

A Multicenter, Phase II Trial of RC48-ADC Combined with Radiotherapy, PD-1/PD-L1 Inhibitor, GM-CSF, and Sequential IL-2 (prag3.0 Regimen) for Salvage Therapy in Patients with HER2-expressing Advanced Solid Tumors

Meiling Xu,Rongzheng Chen,Pengfei Xing,Yuehong Kong, Xiangrong Zhao, Junjun Zhang, Shang Cai,Liyuan Zhang

Journal of Clinical Oncologyno. 16_suppl (2023): e14614-e14614

引用0浏览0引用

PRaG Regimens for Rechallenge in a Patient with Acquired Resistance to PD-1 Inhibitor in Advanced Refractory Renal Pelvis Carcinoma: A Case Report

Zhihui Hong, Hong Xu,Yuehong Kong,Meiling Xu, Yifu Ma,Pengfei Xing,Liyuan Zhang

Advances in Radiotherapy &amp Nuclear Medicineno. 0 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn